NM
Nello Mainolfi (Chief Executive Officer) filed 7 Form 4 reports in the trailing twelve months (0 purchases, 7 sales), most often in Kymera Therapeutics, Inc. (KYMR). The largest single filing was $9.2M of KYMR (80,000 sh across 5 lots, as filed), executed Jul 1. Data as of Nov 7 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
7
0 buys · 7 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$34.9M
shares × price, as filed
Last traded
Oct 1
Filed Oct 1
Median ADV $102.3M across their filed names
Open performance→Volume by month
Buys $0
Sells $39.7M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
7 filings
Sector per market data · by filing · past 12 months
Most traded names
KYMRRecent filings
KYMRSALE
Kymera Therapeutics, Inc.
View filing →
$3.4M29,738 sh across 5 lots
Exec Oct 1
Filed Oct 1 · 5:20 PM ET KYMRSALE Kymera Therapeutics, Inc. View filing → $6.0M
50,000 sh × $119.00
Exec Jul 7
Filed Jul 7 · 8:00 PM ET KYMRSALE Kymera Therapeutics, Inc. View filing → $9.2M
80,000 sh across 5 lots
Exec Jul 1
Filed Jul 2 · 6:30 PM ET KYMRSALE Kymera Therapeutics, Inc. View filing → $2.4M
29,064 sh across 2 lots
Exec Apr 29
Filed Apr 29 · 5:30 PM ET KYMRSALE Kymera Therapeutics, Inc. View filing → $2.7M
29,992 sh across 4 lots
Exec Feb 25
Filed Feb 25 · 5:30 PM ET KYMRSALE Kymera Therapeutics, Inc. View filing → $2.3M
30,000 sh across 2 lots
Exec Dec 31 2025
Filed Dec 31 2025 · 5:30 PM ET KYMRSALE Kymera Therapeutics, Inc. View filing → $8.9M
100,000 sh × $89.17
Exec Dec 8 2025
Filed Dec 8 2025 · 5:30 PM ET KYMRSALE Kymera Therapeutics, Inc. View filing → $1.8M
30,000 sh across 3 lots
Exec Oct 29 2025
Filed Oct 29 2025 · 5:30 PM ET More filings →